Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetr ahydro5-methyl-4-6-oxo-2-piperidinyl]amino)-3 -methoxy-N-(1-methyl-4-piperidinyl) benzamide, methods for the production thereof, and use thereof as medicaments

Details for Australian Patent Application No. 2005274340 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Sieger, Peter; Rall, Werner; Hoffmann, Matthias; Schmid, Rolf; Linz, Guenter; Herter, Rolf; Kraemer, Gerd F.

Agent Davies Collison Cave

Pub. Number AU-B-2005274340

PCT Pub. Number WO2006/018222

Priority 04019366.6 14.08.04 EP

Filing date 11 August 2005

Wipo publication date 23 February 2006

Acceptance publication date 5 April 2012

International Classifications

C07D 475/00 (2006.01) Heterocyclic compounds containing pteridine ring systems

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/018222 Priority application(s): WO2006/018222

5 April 2012 Application Accepted

  Published as AU-B-2005274340

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274368-Hearing protection and/or loudspeaker element

2005274339-Dihydropteridinone infusion solution having a long shelf life